Healing the Cornea: Exploring the Therapeutic Solutions Offered by MSCs and MSC-derived EVs DOI Creative Commons
Manon Jammes,

Abbas Tabasi,

Thorsten Bach

и другие.

Progress in Retinal and Eye Research, Год журнала: 2024, Номер unknown, С. 101325 - 101325

Опубликована: Дек. 1, 2024

Язык: Английский

Ten-year outcomes after DMEK, DSAEK, and PK: insights on graft survival, endothelial cell density loss, rejection and visual acuity DOI Creative Commons
T Wilhelm,

Laura Gauché,

Daniel Böhringer

и другие.

Scientific Reports, Год журнала: 2025, Номер 15(1)

Опубликована: Янв. 8, 2025

Abstract Fuchs Endothelial Corneal Dystrophy (FECD) is the most frequent indication for corneal transplantation, with Descemet membrane endothelial keratoplasty (DMEK), stripping automated (DSAEK), and penetrating (PK) being viable options. This retrospective study compared 10-year outcomes of these techniques in a large cohort 2956 first-time eyes treated FECD at high-volume transplant center Germany. While DMEK DSAEK provided faster visual recovery (median time to BSCVA ≥ 6/12 Snellen: 7.8 months, 12.4 PK 37.9 months; cumulative probability Snellen within 5 years: 93%, 83%, 63%), surprisingly exhibited superior long-term graft survival (92% vs. 75% 73% 10 years). cell density (ECD) decreased significantly after DSAEK, potentially contributing their lower (10-year ECD > 1000 cells/mm 2 probability: 3%, 8%, 18%). demonstrated lowest rejection rate (10% years 13% 19% DSAEK). These findings challenge perceived superiority highlight need further investigation into implications accelerated loss DSAEK.

Язык: Английский

Процитировано

1

Biomaterial-based strategies for primary human corneal endothelial cells for therapeutic applications: from cell expansion to transplantable carrier DOI Creative Commons
Myagmartsend Enkhbat, Jodhbir S. Mehta, Gary S. L. Peh

и другие.

Biomaterials Science, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Biomaterial-based strategies, including ECM coatings and functionalized polymers, enable efficient expansion of primary human corneal endothelial cells, addressing donor shortages advancing cell therapy for transplantation.

Язык: Английский

Процитировано

0

Bioingeniería del Endotelio Corneal: Hacia la Solución de la Escasez de Donantes de Córnea DOI

Judith Zavala Arcos,

Carlos-Alberto Rodríguez-Barrientos,

Itzel Becerril Rojas

и другие.

Highlights of ophthalmology., Год журнала: 2025, Номер 53(1S), С. 14 - 20

Опубликована: Фев. 13, 2025

Процитировано

0

Bioengineering of the Corneal Endothelium: Towards Solving the Corneal Scarcity of Donors DOI

Judith Zavala Arcos,

Carlos-Alberto Rodríguez-Barrientos,

Itzel Becerril Rojas

и другие.

Highlights of ophthalmology., Год журнала: 2025, Номер 53(1E), С. 14 - 20

Опубликована: Фев. 13, 2025

Язык: Английский

Процитировано

0

How “Omics” Studies Contribute to a Better Understanding of Fuchs’ Endothelial Corneal Dystrophy DOI Creative Commons
Erika Prašnikar, Spela Stunf Pukl

Current Issues in Molecular Biology, Год журнала: 2025, Номер 47(3), С. 135 - 135

Опубликована: Фев. 20, 2025

Fuchs’ endothelial corneal dystrophy (FECD) is a progressive eye disease characterized by accelerated loss of cells and the development focal excrescence (guttae) on Descemet’s membrane, resulting in cornea opacity vision deterioration. The FECD assumed to be due interplay between genetic environmental factor risks, causing abnormal extracellular-matrix organization, increased oxidative stress, apoptosis unfolded protein response. However, molecular knowledge limited. genome-wide platforms bioinformatics approaches has enabled us identify numerous loci that are associated with FECD. In this review, we gathered studies (n = 31) sorted them according genomics 9), epigenomics 3), transcriptomics 15), proteomics 3) metabolomics 1) levels characterize progress understanding We also extracted validated differentially expressed/spliced genes proteins identified through comparisons case control groups. addition, highlighted from each omics layer were combined comparison similar study groups original for downstream gene-set enrichment analysis, which provided most significant biological pathways related organization. future, multiomics needed increase sample size statistical power strong candidate functional animal models cell lines better

Язык: Английский

Процитировано

0

Reply DOI

Oliver Dorado Cortez,

Philippe Gain,

Gilles Thuret

и другие.

Cornea, Год журнала: 2025, Номер unknown

Опубликована: Март 7, 2025

Dorado Cortez, Oliver MD; Gain, Philippe MD, PhD; Thuret, Gilles PhD Author Information

Язык: Английский

Процитировано

0

Prevalence and morphometric characteristics of primary cornea guttata in a Hispanic population DOI
Gustavo Ortiz-Morales, Andrés Bustamante-Arias, Manuel E. Quiroga-Garza

и другие.

International Ophthalmology, Год журнала: 2025, Номер 45(1)

Опубликована: Март 30, 2025

Язык: Английский

Процитировано

0

Corneal endothelial dysfunction treatments: Recent advances in non-invasive treatment strategies DOI Creative Commons
Nataliia Gnyliukh, Rabah Boukherroub, Sabine Szunerits

и другие.

Nano Today, Год журнала: 2025, Номер 63, С. 102740 - 102740

Опубликована: Апрель 4, 2025

Язык: Английский

Процитировано

0

From Genes to Disease: Reassessing LOXHD1 and AGBL1’s Contribution to Fuchs’ Dystrophy DOI Open Access
Tatiana Romanovna Tsedilina, Elena I. Sharova,

Aleksandra V. Kanygina

и другие.

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(7), С. 3343 - 3343

Опубликована: Апрель 3, 2025

Fuchs' endothelial corneal dystrophy (FECD) is a genetically complex eye disease associated with multiple genes. A recent systematic review has raised concerns about the causal role of variants in LOXHD1 and AGBL1 genes development FECD. Conflicting data have been reported on expression endothelium. Furthermore, only partial segregation was observed familial cases. An analysis published datasets conducted to examine normal FECD-affected endothelia progenitor cells. Neither nor were expressed or FECD In-house cohorts screened for carriers previously variants. Carriers their first-degree relatives invited an ophthalmological examination reassess relationship these phenotype. Three (one carrier rs200242497 two rs192376005) (rs181958589 rs185919705) recruited. None over 50 years exhibited phenotypic signs via ophthalmic examination. The found not confirmed. Taken together, our findings do support

Язык: Английский

Процитировано

0

Applications of Imaging Technologies in Fuchs Endothelial Corneal Dystrophy: A Narrative Literature Review DOI Creative Commons
Sang Beom Han, Yu‐Chi Liu, Chang Liu

и другие.

Bioengineering, Год журнала: 2024, Номер 11(3), С. 271 - 271

Опубликована: Март 11, 2024

Fuchs endothelial corneal dystrophy (FECD) is a complex genetic disorder characterized by the slow and progressive degeneration of cells. Thus, it may result in decompensation irreversible edema. Moreover, FECD associated with alterations all layers, such as thickening Descemet membrane, stromal scarring, subepithelial fibrosis, formation epithelial bullae. Hence, anterior segment imaging devices that enable precise measurement functional anatomical changes cornea are essential for management FECD. In this review, authors will introduce studies on application various modalities, optical coherence tomography, Scheimpflug specular microscopy, vitro confocal retroillumination photography, diagnosis monitoring discuss results these studies. The novel technologies, including image processing technology artificial intelligence, expected to further enhance accuracy, precision, speed technologies also be discussed.

Язык: Английский

Процитировано

0